Lines of Business (Tables)

12 Months Ended

Dec. 31, 2013

Segment Reporting Information [Line Items]

Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]

The table below lists our revenue by geographic area for fiscal 2013, 2012 and 2011 (in thousands):

	2013		2012		2011
Revenue*
United States	$	1,671,170	$	1,589,588	$	1,474,294
Canada	132,199		110,054		11,067
Total	$	1,803,369	$	1,699,642	$	1,485,361

*Revenues are determined based on the location of the customer. Long-lived assets were not disclosed, as the amounts attributable to the Canadian operations are immaterial, as compared to total consolidated long-lived assets.

Lines of Business

The following is a summary of certain financial data for each of our segments (in thousands):

	Animal Hospital		Laboratory			All Other			Corporate			Eliminations			Total
2013
External revenue	$	1,417,908	$	290,583		$	91,686		$	—		$	3,192		$	1,803,369
Intercompany revenue	—		54,248			21,054			—			(75,302		)	—
Total revenue	1,417,908		344,831			112,740			—			(72,110		)	1,803,369
Direct costs	1,208,781		180,952			74,139			—			(69,883		)	1,393,989
Gross profit	209,127		163,879			38,601			—			(2,227		)	409,380
Selling, general and administrative expense	34,133		31,915			32,941			58,922			—			157,911
Operating income (loss) before charges	174,994		131,964			5,660			(58,922		)	(2,227		)	251,469
Net loss (gain) on sale of assets	2,853		(77		)	7			(328		)	—			2,455
Operating income (loss)	$	172,141	$	132,041		$	5,653		$	(58,594	)	$	(2,227	)	$	249,014
Depreciation and amortization	$	57,748	$	10,251		$	7,909		$	3,284		$	(1,783	)	$	77,409
Capital expenditures	$	54,116	$	11,148		$	4,288		$	5,908		$	(2,190	)	$	73,270
Total assets at December 31, 2013	$	1,854,609	$	247,591		$	96,245		$	77,153		$	(37,817	)	$	2,237,781
2012
External revenue	$	1,331,314	$	275,406		$	90,616		$	—		$	2,306		$	1,699,642
Intercompany revenue	—		52,395			22,344			—			(74,739		)	—
Total revenue	1,331,314		327,801			112,960			—			(72,433		)	1,699,642
Direct costs	1,142,203		176,040			74,253			—			(67,828		)	1,324,668
Gross profit	189,111		151,761			38,707			—			(4,605		)	374,974
Selling, general and administrative expense	30,826		29,660			37,879			58,790			—			157,155
Operating income (loss) before charges	158,285		122,101			828			(58,790		)	(4,605		)	217,819
Impairment of goodwill and other long-lived assets	1,216		—			122,357			—			—			123,573
Net loss (gain) on sale of assets	713		(14		)	717			(106		)	—			1,310
Operating income (loss)	$	156,356	$	122,115		$	(122,246	)	$	(58,684	)	$	(4,605	)	$	92,936
Depreciation and amortization	$	54,835	$	10,141		$	9,582		$	3,198		$	(1,529	)	$	76,227
Capital expenditures	$	55,651	$	8,334		$	5,921		$	9,695		$	(2,794	)	$	76,807
Total assets at December 31, 2012	$	1,648,578	$	244,551		$	98,159		$	127,963		$	(27,671	)	$	2,091,580
2011
External revenue	$	1,150,120	$	272,468		$	61,736		$	—		$	1,037		$	1,485,361
Intercompany revenue	—		44,329			18,694			—			(63,023		)	—
Total revenue	1,150,120		316,797			80,430			—			(61,986		)	1,485,361
Direct costs	970,310		173,007			59,459			—			(55,872		)	1,146,904
Gross profit	179,810		143,790			20,971			—			(6,114		)	338,457
Selling, general and administrative expense	24,342		27,864			19,136			49,770			—			121,112
Operating income (loss) before charges	155,468		115,926			1,835			(49,770		)	(6,114		)	217,345
Goodwill impairment	—		—			21,310			—			—			21,310
Net loss on sale of assets	327		21			27			7			—			382
Operating income (loss)	$	155,141	$	115,905		$	(19,502	)	$	(49,777	)	$	(6,114	)	$	195,653
Depreciation and amortization	$	40,319	$	10,111		$	5,022		$	2,853		$	(1,317	)	$	56,988
Capital expenditures	$	45,753	$	6,082		$	6,448		$	7,299		$	(2,097	)	$	63,485
Total assets at December 31, 2011	$	1,439,103	$	232,423		$	202,187		$	142,793		$	(21,138	)	$	1,995,368